India Biologics Market Size, Share, Trends & Forecast

The India Biologics Market is expanding as demand for advanced therapies, vaccines, biosimilars, and targeted treatments increases across the country. Market Research Future estimates that the market was valued at USD 30.81 billion in 2024 and is projected to reach USD 166.91 billion by 2035, growing at a CAGR of 16.6% from 2025 to 2035.

Rising healthcare expenditure, increasing chronic disease prevalence, and greater access to innovative medicines are supporting market development. India is also strengthening its position as a biopharmaceutical manufacturing hub, attracting investments from domestic and international companies.

Government initiatives supporting biotechnology research and healthcare innovation are further encouraging development of new biologic products. The emphasis on affordable therapies is particularly relevant as manufacturers seek to expand access to complex biological medicines.

Read More
Lukoon https://lukoon.com